Creo Medical Group PLC CREO.L Stock
Creo Medical Group PLC Price Chart
Creo Medical Group PLC CREO.L Financial and Trading Overview
Creo Medical Group PLC stock price | 35.25 GBP |
Previous Close | 36.5 GBP |
Open | 37 GBP |
Bid | 36.5 GBP x 0 |
Ask | 37 GBP x 0 |
Day's Range | 36 - 37.44 GBP |
52 Week Range | 18.34 - 40.5 GBP |
Volume | 63.19K GBP |
Avg. Volume | 629.49K GBP |
Market Cap | 132.76M GBP |
Beta (5Y Monthly) | 0.718 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.07 GBP |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 99.5 GBP |
CREO.L Valuation Measures
Enterprise Value | 80.63M GBP |
Trailing P/E | N/A |
Forward P/E | -11.413043 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.535848 |
Price/Book (mrq) | 141.89189 |
Enterprise Value/Revenue | 2.755 |
Enterprise Value/EBITDA | -3.137 |
Trading Information
Creo Medical Group PLC Stock Price History
Beta (5Y Monthly) | 0.718 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 40.5 GBP |
52 Week Low | 18.34 GBP |
50-Day Moving Average | 33.56 GBP |
200-Day Moving Average | 31.03 GBP |
CREO.L Share Statistics
Avg. Volume (3 month) | 629.49K GBP |
Avg. Daily Volume (10-Days) | 423.38K GBP |
Shares Outstanding | 361.25M |
Float | 217.03M |
Short Ratio | N/A |
% Held by Insiders | 20.10% |
% Held by Institutions | 43.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -85.53% |
Operating Margin (ttm) | -85.35% |
Gross Margin | 48.24% |
EBITDA Margin | -87.81% |
Management Effectiveness
Return on Assets (ttm) | -19.97% |
Return on Equity (ttm) | -38.48% |
Income Statement
Revenue (ttm) | 29.27M GBP |
Revenue Per Share (ttm) | 0.13 GBP |
Quarterly Revenue Growth (yoy) | 15.40% |
Gross Profit (ttm) | N/A |
EBITDA | -25702000 GBP |
Net Income Avi to Common (ttm) | -25036000 GBP |
Diluted EPS (ttm) | -0.11 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 26.5M GBP |
Total Cash Per Share (mrq) | 0.1 GBP |
Total Debt (mrq) | 9.2M GBP |
Total Debt/Equity (mrq) | 13.33 GBP |
Current Ratio (mrq) | 4.126 |
Book Value Per Share (mrq) | 0.259 |
Cash Flow Statement
Operating Cash Flow (ttm) | -23554000 GBP |
Levered Free Cash Flow (ttm) | -20509876 GBP |
Profile of Creo Medical Group PLC
Country | United Kingdom |
State | N/A |
City | Chepstow |
Address | Creo House |
ZIP | NP16 5UH |
Phone | 44 12 9160 6005 |
Website | https://creomedical.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 279 |
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle. Creo Medical Group PLC was founded in 2003 and is based in Chepstow, the United Kingdom.
Q&A For Creo Medical Group PLC Stock
What is a current CREO.L stock price?
Creo Medical Group PLC CREO.L stock price today per share is 35.25 GBP.
How to purchase Creo Medical Group PLC stock?
You can buy CREO.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Creo Medical Group PLC?
The stock symbol or ticker of Creo Medical Group PLC is CREO.L.
Which industry does the Creo Medical Group PLC company belong to?
The Creo Medical Group PLC industry is Medical Devices.
How many shares does Creo Medical Group PLC have in circulation?
The max supply of Creo Medical Group PLC shares is 3.61M.
What is Creo Medical Group PLC Price to Earnings Ratio (PE Ratio)?
Creo Medical Group PLC PE Ratio is now.
What was Creo Medical Group PLC earnings per share over the trailing 12 months (TTM)?
Creo Medical Group PLC EPS is -0.07 GBP over the trailing 12 months.
Which sector does the Creo Medical Group PLC company belong to?
The Creo Medical Group PLC sector is Healthcare.